648 related articles for article (PubMed ID: 32861822)
21. Therapeutic Potential of Hematopoietic Stem Cell-Derived Exosomes in Cardiovascular Disease.
Radosinska J; Bartekova M
Adv Exp Med Biol; 2017; 998():221-235. PubMed ID: 28936743
[TBL] [Abstract][Full Text] [Related]
22. Appearance of claudin-5
Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
[TBL] [Abstract][Full Text] [Related]
23. Extracellular Vesicles as Messengers in Atherosclerosis.
Peng M; Liu X; Xu G
J Cardiovasc Transl Res; 2020 Apr; 13(2):121-130. PubMed ID: 31664614
[TBL] [Abstract][Full Text] [Related]
24. Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles.
Davidson SM; Boulanger CM; Aikawa E; Badimon L; Barile L; Binder CJ; Brisson A; Buzas E; Emanueli C; Jansen F; Katsur M; Lacroix R; Lim SK; Mackman N; Mayr M; Menasché P; Nieuwland R; Sahoo S; Takov K; Thum T; Vader P; Wauben MHM; Witwer K; Sluijter JPG
Cardiovasc Res; 2023 Mar; 119(1):45-63. PubMed ID: 35325061
[TBL] [Abstract][Full Text] [Related]
25. Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis.
Dolcetti E; Bruno A; Guadalupi L; Rizzo FR; Musella A; Gentile A; De Vito F; Caioli S; Bullitta S; Fresegna D; Vanni V; Balletta S; Sanna K; Buttari F; Stampanoni Bassi M; Centonze D; Mandolesi G
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33020408
[TBL] [Abstract][Full Text] [Related]
26. Extracellular vesicles in cardiovascular disease.
Huang C; Neupane YR; Lim XC; Shekhani R; Czarny B; Wacker MG; Pastorin G; Wang JW
Adv Clin Chem; 2021; 103():47-95. PubMed ID: 34229852
[TBL] [Abstract][Full Text] [Related]
27. Extracellular vesicles derived from Krüppel-Like Factor 2-overexpressing endothelial cells attenuate myocardial ischemia-reperfusion injury by preventing Ly6C
Qiao S; Zhang W; Yin Y; Wei Z; Chen F; Zhao J; Sun X; Mu D; Xie J; Xu B
Theranostics; 2020; 10(25):11562-11579. PubMed ID: 33052233
[No Abstract] [Full Text] [Related]
28. Emerging role of extracellular vesicles in lung injury and inflammation.
Lanyu Z; Feilong H
Biomed Pharmacother; 2019 May; 113():108748. PubMed ID: 30877881
[TBL] [Abstract][Full Text] [Related]
29. Stem cell- derived extracellular vesicles as new tools in regenerative medicine - Immunomodulatory role and future perspectives.
Karnas E; Dudek P; Zuba-Surma EK
Front Immunol; 2023; 14():1120175. PubMed ID: 36761725
[TBL] [Abstract][Full Text] [Related]
30. Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes.
Beez CM; Haag M; Klein O; Van Linthout S; Sittinger M; Seifert M
J Nanobiotechnology; 2019 May; 17(1):72. PubMed ID: 31133024
[TBL] [Abstract][Full Text] [Related]
31. Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis.
Georgescu A; Simionescu M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073119
[TBL] [Abstract][Full Text] [Related]
32. Monocyte-derived extracellular vesicles stimulate cytokine secretion and gene expression of matrix metalloproteinases by mesenchymal stem/stromal cells.
Gebraad A; Kornilov R; Kaur S; Miettinen S; Haimi S; Peltoniemi H; Mannerström B; Seppänen-Kaijansinkko R
FEBS J; 2018 Jun; 285(12):2337-2359. PubMed ID: 29732732
[TBL] [Abstract][Full Text] [Related]
33. The good, the bad and the ugly: the impact of extracellular vesicles on the cardiovascular system.
Martins-Marques T; Girão H
J Physiol; 2023 Nov; 601(22):4837-4852. PubMed ID: 35348208
[TBL] [Abstract][Full Text] [Related]
34. EVs predict the outcomes in patients with acute myocardial infarction.
El-Khsosy A; Mohamed MA; Khaled A; Mohamed NA; Shalabi SS
Tissue Cell; 2022 Aug; 77():101857. PubMed ID: 35779286
[TBL] [Abstract][Full Text] [Related]
35. Multifaceted role of extracellular vesicles in atherosclerosis.
Konkoth A; Saraswat R; Dubrou C; Sabatier F; Leroyer AS; Lacroix R; Duchez AC; Dignat-George F
Atherosclerosis; 2021 Feb; 319():121-131. PubMed ID: 33261815
[TBL] [Abstract][Full Text] [Related]
36. Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles.
Giricz Z; Varga ZV; Baranyai T; Sipos P; Pálóczi K; Kittel Á; Buzás EI; Ferdinandy P
J Mol Cell Cardiol; 2014 Mar; 68():75-8. PubMed ID: 24440457
[TBL] [Abstract][Full Text] [Related]
37. Extracellular Vesicles and Ischemic Cardiovascular Diseases.
Zhu Y; Wang S; Chen X
Adv Exp Med Biol; 2023; 1418():57-68. PubMed ID: 37603272
[TBL] [Abstract][Full Text] [Related]
38. Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction.
Gasecka A; Nieuwland R; Budnik M; Dignat-George F; Eyileten C; Harrison P; Huczek Z; Kapłon-Cieślicka A; Lacroix R; Opolski G; Pluta K; van der Pol E; Postuła M; Leroyer A; Siljander P; Sturk A; Filipiak KJ
Platelets; 2020; 31(1):26-32. PubMed ID: 30585111
[TBL] [Abstract][Full Text] [Related]
39. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.
Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF
Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585
[TBL] [Abstract][Full Text] [Related]
40. Extracellular Vesicles in Angiogenesis.
Todorova D; Simoncini S; Lacroix R; Sabatier F; Dignat-George F
Circ Res; 2017 May; 120(10):1658-1673. PubMed ID: 28495996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
